Implementation of an Interleukin-2 National Registry: an opportunity to improve cancer outcomes

Cancer registries have proven valuable with respect to validating therapeutic safety and drug efficacy, uncovering real-world implementation practices, and their evolution over time. Modern cancer therapeutics are approved as single agents oftentimes compared to the least active approved standard ag...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Wong, Michael K, Kaufman, Howard L, Daniels, Gregory A, McDermott, David F, Aung, Sandra, Lowder, James N, Morse, Michael A
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2014
Matèries:
Commentary
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4100489/
https://ncbi.nlm.nih.gov/pubmed/25031835
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2051-1426-2-20
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars